Activity of Deferasirox in Mucorales: Influences of Species and Exogenous Iron

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00792-10
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Deferasirox, an Oral Iron Chelator, Prevents Hepatocarcinogenesis and Adverse Effects of Sorafenib

Journal of Clinical Biochemistry and Nutrition
MedicineNutritionClinical BiochemistryDietetics
2016English

PO-0161 Treatment of Iron Overload With Deferasirox in the Patients With Thalassaemia Major

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2014English

Hepatoprotective Activity of Exogenous RNA

Ukrainian Biochemical Journal
Biochemistry
2015English

Simultaneous Detection and Identification of Aspergillus and Mucorales Species in Tissues Collected From Patients With Fungal Rhinosinusitis

Journal of Clinical Microbiology
Microbiology
2011English

Effects of Exogenous Antioxidants on Dietary Iron Overload

Journal of Clinical Biochemistry and Nutrition
MedicineNutritionClinical BiochemistryDietetics
2009English

Deferasirox in MDS Patients With Transfusion-Caused Iron Overload—a Phase-Ii Study

Annals of Hematology
MedicineHematology
2008English

Genes, Pathways, and Mechanisms Involved in the Virulence of Mucorales

Genes
Genetics
2020English

Identifying Exogenous and Endogenous Activity in Social Media

Physical review. E
Nonlinear PhysicsProbabilityStatisticsCondensed Matter PhysicsStatistical
2018English

Daily Alternating Deferasirox and Deferiprone Therapy Successfully Controls Iron Accumulation in Untreatable Transfusion Dependent Thalassemia Patients

American Journal of Hematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy